Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Analysis of endocannabinoid receptors and enzymes in the post-mortem motor cortex and spinal cord of amyotrophic lateral sclerosis patients
Authors
Keywords
-
Journal
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
Volume 19, Issue 5-6, Pages 377-386
Publisher
Informa UK Limited
Online
2018-01-16
DOI
10.1080/21678421.2018.1425454
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
- (2016) Fabio Arturo Iannotti et al. PROGRESS IN LIPID RESEARCH
- Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders
- (2015) Francisco Espejo-Porras et al. Journal of Neuroimmune Pharmacology
- Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease
- (2015) María Concepción García et al. NEUROSCIENCE LETTERS
- Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications
- (2015) Javier Fernández-Ruiz et al. Neurotherapeutics
- Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism
- (2014) Salvador Sierra et al. Brain Structure & Function
- Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93ATransgenic Mice and Evaluation of a Sativex®-like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis
- (2014) Miguel Moreno-Martet et al. CNS Neuroscience & Therapeutics
- Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias
- (2014) Carmen Rodríguez-Cueto et al. PATHOBIOLOGY
- Changes in CB1and CB2receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias
- (2013) Carmen Rodríguez-Cueto et al. BRITISH JOURNAL OF PHARMACOLOGY
- State of play in amyotrophic lateral sclerosis genetics
- (2013) Alan E Renton et al. NATURE NEUROSCIENCE
- The epidemiology of ALS: a conspiracy of genes, environment and time
- (2013) Ammar Al-Chalabi et al. Nature Reviews Neurology
- Current insights into the C9orf72 repeat expansion diseases of the FTLD/ALS spectrum
- (2013) Marc Cruts et al. TRENDS IN NEUROSCIENCES
- Emerging drug targets in amyotrophic lateral sclerosis
- (2013) Michael P Bova et al. Expert Opinion on Orphan Drugs
- Emerging drugs for amyotrophic lateral sclerosis
- (2011) Ali Aamer Habib et al. EXPERT OPINION ON EMERGING DRUGS
- Clinical diagnosis and management of amyotrophic lateral sclerosis
- (2011) Orla Hardiman et al. Nature Reviews Neurology
- CB2: a cannabinoid receptor with an identity crisis
- (2010) Brady K Atwood et al. BRITISH JOURNAL OF PHARMACOLOGY
- TDP-43 and FUS/TLS: emerging roles in RNA processing and neurodegeneration
- (2010) C. Lagier-Tourenne et al. HUMAN MOLECULAR GENETICS
- Expression of the mRNA coding the cannabinoid receptor 2 in the pallidal complex of Macaca fascicularis
- (2010) José L Lanciego et al. JOURNAL OF PSYCHOPHARMACOLOGY
- The multiple roles of TDP-43 in pre-mRNA processing and gene expression regulation
- (2010) Emanuele Buratti et al. RNA Biology
- Expression of mutant SOD1G93Ain astrocytes induces functional deficits in motoneuron mitochondria
- (2008) Lynsey G. Bilsland et al. JOURNAL OF NEUROCHEMISTRY
- Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- (2008) Francisco J Alvarez et al. PEDIATRIC RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started